Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000166

EVP, Chief Reg. & Quality Off. sold 4,600 shares at an average $441.99 ($2,033,159)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-30 Sale : show line 1 in the form 10b5-1 −2,350 $439.11 $1,031,909 53,523 D
2024-05-31 Sale : show line 2 in the form 10b5-1 −2,250 $445.00 $1,001,250 51,273 D
Open-market sales · 4,600 sh · avg $441.99 · $2,033,159
Loading xslF345X05/wk-form4_1717445345.xml…